These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7357508)

  • 1. Combination clinical trials with thymidine and fluorouracil: a phase I and clinical pharmacologic evaluation.
    Woodcock TM; Martin DS; Damin LA; Kemeny NE; Young CW
    Cancer; 1980 Mar; 45(5 Suppl):1135-43. PubMed ID: 7357508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacologic effects of thymidine plus 5-FU.
    Ohnuma T; Roboz J; Waxman S; Mandel E; Martin DS; Holland JF
    Cancer Treat Rep; 1980; 64(12):1169-77. PubMed ID: 7471111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapeutic efficacy of 5-fluorouracil with concurrent thymidine infusion against transplantable colon tumors in rodents.
    Danhauser LL; Rustum YM
    Cancer Drug Deliv; 1984; 1(4):269-82. PubMed ID: 6549560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combination of 5-fluorouracil and thymidine in advanced colorectal carcinoma.
    Sternberg A; Petrelli NJ; Au J; Rustum Y; Mittelman A; Creaven P
    Cancer Chemother Pharmacol; 1984; 13(3):218-22. PubMed ID: 6488442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I evaluation and pharmacokinetic study of weekly iv thymidine and 5-FU in patients with advanced colorectal carcinoma.
    Lynch G; Kemeny N; Chun H; Martin D; Young C
    Cancer Treat Rep; 1985 Feb; 69(2):179-84. PubMed ID: 3971391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential administration of thymidine, 5-fluorouracil, and PALA. A phase I-II study.
    Chiuten DF; Miller A; Valdivieso M; Loo TL; Bedikian A; Bodey GP; Benvenuto JA; Freireich EJ
    Am J Clin Oncol; 1985 Aug; 8(4):332-5. PubMed ID: 4083263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I study of thymidine plus 5-fluorouracil infusions in advanced colorectal carcinoma.
    Vogel SJ; Presant CA; Ratkin GA; Klahr C
    Cancer Treat Rep; 1979 Jan; 63(1):1-5. PubMed ID: 369680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of thymidine.
    Martin DS; Stolfi RL; Sawyer RC; Nayak R; Spiegelman S; Young CW; Woodcock T
    Cancer; 1980 Mar; 45(5 Suppl):1117-28. PubMed ID: 6986974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of 5-FU action by thymidine in murine and human tumors.
    Young CW; Woodcock TM; Martin DS
    Cancer Treat Rep; 1981; 65 Suppl 3():83-7. PubMed ID: 7346156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I evaluation of a biochemically designed combination: PALA, thymidine, and 5-FU.
    Casper ES; Michaelson RA; Kemeny N; Martin DS; Young CW
    Cancer Treat Rep; 1984 Mar; 68(3):539-41. PubMed ID: 6704982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement by thymidine of 5-fluorouracil's inhibition of thymidylate synthetase in human tumors.
    Wolberg WH
    Cancer Treat Rep; 1979; 63(11-12):1817-20. PubMed ID: 526916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma.
    Buroker TR; Moertel CG; Fleming TR; Everson LK; Cullinan SA; Krook JE; Mailliard JA; Marschke RF; Klaassen DJ; Laurie JA
    J Clin Oncol; 1985 Dec; 3(12):1624-31. PubMed ID: 2933492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of 5-fluorouracil metabolism by thymidine. In vivo and in vitro studies on RNA-directed effects in rat liver and hepatoma.
    Engelbrecht C; Ljungquist I; Lewan L; Yngner T
    Biochem Pharmacol; 1984 Mar; 33(5):745-50. PubMed ID: 6201174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trial of sequential N-phosphonacetyl-L-aspartate, thymidine, and 5-fluorouracil in advanced colorectal carcinoma.
    O'Connell MJ; Moertel CG; Rubin J; Hahn RG; Kvols LK; Schutt AJ
    J Clin Oncol; 1984 Oct; 2(10):1133-8. PubMed ID: 6491697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of folinic acid on fluorouracil activity and expression of thymidylate synthase.
    van der Wilt CL; Pinedo HM; Smid K; Cloos J; Noordhuis P; Peters GJ
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):16-25. PubMed ID: 1532671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevention of methotrexate toxicity by thymidine infusions in humans.
    Ensminger WD; Frei E
    Cancer Res; 1977 Jun; 37(6):1857-63. PubMed ID: 870189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I-II clinical trial of thymidine, 5-FU, and PALA given in combination.
    Chiuten DF; Valdivieso M; Bedikian A; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1985 Jun; 69(6):611-3. PubMed ID: 4016768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymidine and 5-FU: a Phase II pilot study in colorectal and breast carcinomas.
    Presant CA; Multhauf P; Klein L; Chan C; Chang FF; Hum G; Joseph R; Opfell R; Lemkin S; Shiftan T; Plotkin D
    Cancer Treat Rep; 1983; 67(7-8):735-6. PubMed ID: 6871891
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase I-phase II trial of N-phosphonacetyl-L-aspartic acid given by intravenous infusion and 5-fluorouracil given by bolus injection.
    Erlichman C; Donehower RC; Speyer JL; Klecker R; Chabner BA
    J Natl Cancer Inst; 1982 Feb; 68(2):227-31. PubMed ID: 6950156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized phase I and II study of short-term infusion of high-dose fluorouracil with or without N-(phosphonacetyl)-L-aspartic acid in patients with advanced pancreatic and colorectal cancers.
    Ardalan B; Singh G; Silberman H
    J Clin Oncol; 1988 Jun; 6(6):1053-8. PubMed ID: 3373260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.